1965
DOI: 10.1097/00000542-196505000-00013
|View full text |Cite
|
Sign up to set email alerts
|

Metabolism of Volatile Anesthetics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
13
0

Year Published

1970
1970
2012
2012

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 80 publications
(13 citation statements)
references
References 0 publications
0
13
0
Order By: Relevance
“…Since patients are frequently preraedicated prior to anesthesia with agents which increase the biotransformation of anesthetics (Van Dyke and Chenoweth, 1965;Rice, Sbordore, and Masse, 1978), this hypoxic model of halothane hepatotoxicity may more realistically represent the conditions present during clinical anesthesia than previous animal models.…”
Section: Animal Modelsmentioning
confidence: 99%
See 1 more Smart Citation
“…Since patients are frequently preraedicated prior to anesthesia with agents which increase the biotransformation of anesthetics (Van Dyke and Chenoweth, 1965;Rice, Sbordore, and Masse, 1978), this hypoxic model of halothane hepatotoxicity may more realistically represent the conditions present during clinical anesthesia than previous animal models.…”
Section: Animal Modelsmentioning
confidence: 99%
“…Although halothane may be metabolized by both oxidative and reductive routes (Van Dyke and Chenoweth, 1965;Van Dyke and Gandolfi, 1976), its reductive biotransformation appears to lead to bioactivation rather than to detoxification. Uehleke, Hellmer, and TabarelllPoplawski (1973) and Van Dyke and Gandolfi (1974) found that covalent 14 binding of C halothane metabolites was enhanced after anerobic incubation of the radiolabeled anesthetic with isolated hepatic microsomes.…”
Section: Introductionmentioning
confidence: 99%
“…If inorganic fluoride formed from methoxyflurane metabolites is in¬ deed the cause of the polyuria and renal failure, several factors would appear to be important in determin¬ ing whether the high output failure syndrome will develop in a particu¬ lar patient: (1) anesthesia; (2) the amount of anes¬ thetic retained which, in turn, would be related to obesity and the rate of metabolism of the methoxyflurane to nonvolatile components; (3) the rate of clearance of the inorganic and organic fluoride.…”
Section: Commentmentioning
confidence: 99%
“…19 Until recently, it was believed that all inhalational anaesthetics except trichlorethylene were eliminated entirely unchanged through the lungs. It appears now that up to 35 per cent of the inhaled anaesthetic vapours may be biodegraded and, in the case of methoxyflurane, toxic products may accumulate in sufficient quantity to injure vital organs -particularly the kidney.…”
mentioning
confidence: 99%